Biotechnology Company Regeneron to Buy 23andMe for $256 million

A look at why the publicly traded pharmaceutical giant is snapping the genetic-testing company out of bankruptcy.

May 19, 2025 - 17:00
 0
Biotechnology Company Regeneron to Buy 23andMe for $256 million

A look at why the publicly traded pharmaceutical giant is snapping the genetic-testing company out of bankruptcy.